YOQNEAM, Israel, November 12, 2019.
InMode Ltd. (Nasdaq:
INMD
) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Canaccord Genuity MedTech & Diagnostics Forum at the Westin Grand Central, New York City on November 21st at 11:30 am EST.
Mr. Mizrahy will be available for one-on-one meetings during the conference. To schedule a meeting please contact your Canaccord salesperson or Miri Segal at
About Canaccord Genuity MedTech & Diagnostics Forum
Canaccord’s MedTech Conference will profile public and private Med-Tech and Diagnostic companies in Cardiovascular, Diabetes, ENT, Respiratory, Wound Care, Women’s Healthcare, Ophthalmology, Aesthetics, Obesity, Robotics & Imaging, Diagnostics, Liquid Biopsies, Precision Medicine and Next Generation Sequencing.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit
www.inmodemd.com
.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
917-607-8654
